<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01210963</url>
  </required_header>
  <id_info>
    <org_study_id>09/08</org_study_id>
    <nct_id>NCT01210963</nct_id>
  </id_info>
  <brief_title>Central Corneal Thickness With SENSIMED Triggerfish</brief_title>
  <acronym>09/08</acronym>
  <official_title>Central Corneal Thickness After Overnight IOP Monitoring With SENSIMED Triggerfish</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sensimed AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sensimed AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the occurrence of possible corneal swelling after continuous Intraocular&#xD;
      pressure (IOP) monitoring with a contact lens-based Sensor during the sleeping period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pachymetry (central corneal thickness)</measure>
    <time_frame>after 8 hours nocturnal continuous IOP monitoring</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>SENSIMED Triggerfish</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SENSIMED Triggerfish</intervention_name>
    <description>Contact lens-based Sensor with recording system for continuous monitoring of IOP fluctuation</description>
    <arm_group_label>SENSIMED Triggerfish</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Glaucoma and ocular hypertension patients, at least 18 years old and with stable&#xD;
        IOP-lowering treatment (if any).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  glaucoma and ocular hypertension scheduled for overnight hospitalisation&#xD;
&#xD;
          -  stable IOP-lowering treatment since at least 4 weeks before study&#xD;
&#xD;
          -  at least 18 years&#xD;
&#xD;
          -  having provided informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contact lens wear within the last 2 years&#xD;
&#xD;
          -  contraindication for silicone lean wear&#xD;
&#xD;
          -  corneal abnormality in either eye&#xD;
&#xD;
          -  ocular infection or inflammation&#xD;
&#xD;
          -  history of ocular surgery within the last 3 months&#xD;
&#xD;
          -  full-frame metal glasses during IOP monitoring with SENSIMED Triggerfish&#xD;
&#xD;
          -  pregnancy and lactation&#xD;
&#xD;
          -  patients not able to understand the nature of the research&#xD;
&#xD;
          -  patients under tutelage&#xD;
&#xD;
          -  patients committed to an institution by virtue of an order issued either by the courts&#xD;
             or by an authority&#xD;
&#xD;
          -  simultaneous participation in other clinical research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Klink, PD Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Augen- und Poliklinik, Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <study_first_submitted>September 27, 2010</study_first_submitted>
  <study_first_submitted_qc>September 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2010</study_first_posted>
  <last_update_submitted>March 17, 2011</last_update_submitted>
  <last_update_submitted_qc>March 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>Priv. Doz. Dr. med. Thomas Klink</name_title>
    <organization>Universitätsklinikum Würzburg, Augen- und Poliklinik</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

